These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 37964021)
1. A different perspective on PET/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters. Aksu A; Küçüker KA; Solmaz Ş; Turgut B Ann Hematol; 2024 Mar; 103(3):813-822. PubMed ID: 37964021 [TBL] [Abstract][Full Text] [Related]
2. The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC. Agüloğlu N; Aksu A; Unat DS; Akyol M Nucl Med Commun; 2022 Dec; 43(12):1217-1224. PubMed ID: 36345766 [TBL] [Abstract][Full Text] [Related]
3. Volumetric parameters from [ Langen Stokmo H; Aly M; Bowitz Lothe IM; Borja AJ; Mehdizadeh Seraj S; Ghorpade R; Miao X; Hjortland GO; Malinen E; Sorbye H; Werner TJ; Alavi A; Revheim ME J Neuroendocrinol; 2022 Jul; 34(7):e13170. PubMed ID: 35729738 [TBL] [Abstract][Full Text] [Related]
4. [ Xu HQ; Song LJ; Ding CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1690-1700. PubMed ID: 38071047 [TBL] [Abstract][Full Text] [Related]
5. The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer. Zer A; Domachevsky L; Rapson Y; Nidam M; Flex D; Allen AM; Stemmer SM; Groshar D; Bernstine H Eur Radiol; 2016 Sep; 26(9):3155-61. PubMed ID: 26685851 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the harmonized maximum standardized uptake value of 18F-FDG-PET/CT in patients with resectable oral tongue squamous cell carcinoma: a multicenter study. Kaida H; Kitajima K; Sekine T; Ito K; Daisaki H; Kimura T; Sato MP; Enomoto A; Otsuki N; Ishii K Dentomaxillofac Radiol; 2023 Oct; 52(7):20230083. PubMed ID: 37494001 [TBL] [Abstract][Full Text] [Related]
7. Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin Lymphoma. Camacho MR; Etchebehere E; Tardelli N; Delamain MT; Vercosa AFA; Takahashi MES; Brunetto SQ; Metze IGHL; Souza CA; Cerci JJ; Ramos CD J Nucl Med Technol; 2020 Mar; 48(1):30-35. PubMed ID: 31604902 [TBL] [Abstract][Full Text] [Related]
8. Value of baseline and end of chemotherapy Xiao Z; Mo Y; Long W; Li R; Li X; Wei Y; Fan W; Zhang X Leuk Lymphoma; 2021 Dec; 62(12):2873-2881. PubMed ID: 34165390 [TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT Maximum Tumor Dissemination to Predict Recurrence in Patients with Diffuse Large B-Cell Lymphoma. Jo JH; Chung HW; Kim SY; Lee MH; So Y Nucl Med Mol Imaging; 2023 Feb; 57(1):26-33. PubMed ID: 36643943 [TBL] [Abstract][Full Text] [Related]
10. Metabolic tumor burden on baseline Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis. Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243 [TBL] [Abstract][Full Text] [Related]
12. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of baseline Zhou Y; Hong Z; Zhou M; Sang S; Zhang B; Li J; Li Q; Wu Y; Deng S J Med Imaging Radiat Oncol; 2020 Feb; 64(1):87-95. PubMed ID: 31880103 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 18F-FDG lesion dissemination features in patients with peripheral T-cell lymphoma (PTCL). Xie Y; Teng Y; Jiang C; Ding C; Zhou Z Jpn J Radiol; 2023 Jul; 41(7):777-786. PubMed ID: 36752954 [TBL] [Abstract][Full Text] [Related]